AMZN
Amazon.com, Inc.
AMZN has lower modeled downside risk, despite its lower overall score.
FIVE
Five Below, Inc.
FIVE has the edge over AMZN overall, supported by stronger fundamentals and stronger valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
FIVE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
FIVE's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over FIVE in the historical PE scenario, which offers more potential upside but is not a forecast.
FIVE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $247 | — |
| Cheap | 23x | $252 | +2.1% |
| Forward | 24x | $247 | — |
| Fair | 35x | $390 | +58% |
| Expensive | 49x | $546 | +121% |
Historical ranges are pointers, not guarantees.
FIVE's PE is in its cheap range at 22x. On analysts' estimates for next year's earnings, today's price would be 24x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
FIVE Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for FIVE, with profitability improving.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over FIVE on earnings, with more consistent year-over-year improvement.
FIVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.31 | -7.5% |
| Q3 2026 | $11.15 | +126% |
| Q2 2026 | $7.93 | +66% |
| Q1 2026 | $6.47 | +41% |
| Q4 2025 | $5.57 | +15% |
| Q3 2025 | $4.94 | -2.8% |
| Q2 2025 | $4.77 | -10% |
| Q1 2025 | $4.59 | -15% |
| Q4 2024 | $4.85 | +0.2% |
FIVE earned $11.15 per share over the past year, up 126% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
FIVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +23% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.7B | +24% |
| Q4 2025 | $1B | +23% |
| Q3 2025 | $1B | +24% |
| Q2 2025 | $970.5M | +20% |
| Q1 2025 | $1.4B | +4% |
| Q4 2024 | $843.7M | +15% |
FIVE has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +17 points |
| Q2 2026 | 12% | +6.8 points |
| Q1 2026 | 18% | +0.3 points |
| Q4 2025 | 4.2% | +4.2 points |
| Q3 2025 | 5.1% | +0.1 points |
| Q2 2025 | 5.2% | +0.8 points |
| Q1 2025 | 18% | -2.3 points |
| Q4 2024 | -0.1% | -2.3 points |
FIVE has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
FIVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $142.3M | +195% |
| Q2 2026 | $190M | +97% |
| Q1 2026 | $400.1M | +28% |
| Q4 2025 | -$133.2M | -$22.2M |
| Q3 2025 | $48.3M | +$80.6M |
| Q2 2025 | $96.5M | +$157.9M |
| Q1 2025 | $311.4M | +2.2% |
| Q4 2024 | -$111M | +$81.9M |
FIVE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
FIVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -133K shares |
| 1 year | +0.2% | +85.1K shares |
| 3 years | -0.6% | -327K shares |
| 5 years | -1.5% | -825K shares |
| Available history | -1% | -545K shares |
FIVE has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $13,000 |
| Q4 2024 | — |
| Q3 2024 | $10.1M |
| Q2 2024 | $30.2M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
FIVE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
FIVE has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
FIVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.9 | Neutral |
| Stochastic | 66.1 | Neutral |
FIVE's weekly RSI is 61 (neutral) and its Stochastic is 66 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over FIVE on valuation relative to its sector.
FIVE PE vs Consumer Cyclical Sector
| Metric | FIVE | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 23% above |
| PE % | 16 | 47 | 31 pts below |
FIVE is trading at 22x earnings, a 23% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
FIVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.1 | 7.9% above |
| 20 week MA | $227.0 | 8.9% above |
| 50 week MA | $215.4 | 15% above |
| 100 week MA | $166.0 | 49% above |
| 200 week MA | $162.4 | 52% above |
FIVE is in an uptrend: it's above all five of its weekly moving averages, and 52% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
FIVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $125.4 | $158.9 | +27% |
| 2021 | $158.9 | $193.6 | +22% |
| 2022 | $193.6 | $174.8 | -9.7% |
| 2023 | $174.8 | $213.2 | +22% |
| 2024 | $213.2 | $109.2 | -49% |
| 2025 | $109.2 | $189.9 | +74% |
| 2026 YTD | $189.9 | $247.2 | +30% |
FIVE has the edge over AMZN on returns for 2026, with the stronger performance.